Moderna, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2018 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Moderna, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q3 2024.
- Moderna, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $8M.
- Moderna, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$129M.
- Moderna, Inc. annual Income Tax Expense (Benefit) for 2023 was $772M, a 36.4% decline from 2022.
- Moderna, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.21B, a 12% increase from 2021.
- Moderna, Inc. annual Income Tax Expense (Benefit) for 2021 was $1.08B, a 36000% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)